Price Alert

Kala Pharmaceuticals Inc. (KALA)

NASDAQ: KALA · Real-Time Price · USD

8.31

0.24 (2.97%)

At close: Aug 15, 2025, 2:58 PM

Kala Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	31.94M	42.22M	51.18M	49.2M	54.2M	48.48M	50.9M	56.06M	49.26M	63.64M	70.5M	52.39M	42.57M	65.17M	92.14M	124.5M	144.63M	127.97M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	9.92M	n/a	n/a	n/a	2M	4.99M	n/a	n/a	5M	28.02M
Long-Term Investments	226K	239K	246K	260K	273K	287K	301K	314K	328K	n/a	462K	n/a	519K	1.43M	1.46M	3.21M	3.22M	12.98M
Other Long-Term Assets	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	372K	n/a	475K	n/a	7.8M	9.58M	11.04M	9.16M	6.2M
Receivables	127K	2.47M	n/a	n/a	3.46M	n/a	236K	272K	306K	1.08M	6.5M	1.03M	13.82M	13.02M	17.45M	12.63M	11.86M	12.21M
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	5.24M	n/a	7.67M	9.66M	25K	10.53M	8.64M	7.71M	8.05M	8.24M
Other Current Assets	1.59M	749K	1.62M	2.08M	495K	1.61M	1.06M	649K	687K	6.63M	8.25M	21.21M	22.96M	4.54M	5.22M	4.25M	2.18M	2.63M
Total Current Assets	33.66M	45.72M	52.8M	51.28M	58.85M	50.09M	52.87M	57.9M	65.53M	71.34M	85.94M	84.67M	83.52M	98.25M	124.37M	149.09M	171.72M	179.06M
Property-Plant & Equipment	2.16M	2.3M	2.44M	2.54M	2.48M	2.66M	2.78M	2.9M	637K	510K	416K	551K	942K	4.09M	4.02M	30.48M	31.37M	31.58M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	2.39M	2.54M	2.69M	2.8M	2.75M	2.95M	3.08M	3.22M	965K	882K	878K	1.03M	1.46M	13.32M	15.06M	44.73M	43.74M	50.76M
Total Assets	36.05M	48.25M	55.48M	54.08M	61.61M	53.03M	55.95M	61.12M	66.5M	72.23M	86.82M	85.7M	84.98M	111.57M	139.43M	193.81M	215.46M	229.83M
Account Payables	658K	931K	628K	711K	665K	732K	919K	787K	760K	997K	2.35M	7.35M	2.44M	2.82M	2.78M	2.44M	2.15M	2.85M
Deferred Revenue	n/a	546K	637K	314K	2.26M	n/a	1.07M	2.93M	4.19M	4.19M	4.19M	3.41M	n/a	n/a	28M	n/a	n/a	n/a
Short-Term Debt	9.92M	15.5M	10.34M	17.98M	11.98M	5.99M	334K	324K	n/a	n/a	5M	32K	52K	625K	n/a	1.89M	1.98M	1.99M
Other Current Liabilities	3.93M	2.6M	2.39M	3.72M	2.17M	3.54M	3.07M	3.15M	3.06M	1.09M	10.8M	29.5M	24.86M	24.09M	27.61M	12.33M	11.94M	7.61M
Total Current Liabilities	16.02M	22.98M	16.96M	23.87M	19.19M	11.88M	8.35M	10.3M	9.85M	10.27M	25.68M	40.24M	32.89M	32.76M	37.42M	27.2M	26.08M	19.99M
Long-Term Debt	1.23M	15.12M	20.1M	17.16M	22.83M	28.51M	34.19M	33.88M	33.57M	33.27M	37.94M	42.64M	79.8M	79.36M	78.93M	78.49M	78.06M	72.52M
Other Long-Term Liabilities	6M	3.12M	4.66M	4.66M	4.24M	4.27M	4.11M	3.84M	5.59M	5.23M	4.22M	3.78M	3.84M	4M	5.72M	n/a	n/a	n/a
Total Long-Term Liabilities	7.23M	19.57M	26.2M	23.35M	28.7M	34.49M	40.1M	39.6M	39.16M	38.5M	42.16M	46.42M	83.64M	84.1M	85.2M	105.15M	105.12M	100.05M
Total Liabilities	39.26M	42.54M	43.15M	47.22M	47.89M	46.37M	48.45M	49.9M	49.01M	48.77M	67.85M	86.67M	116.53M	116.86M	122.62M	132.34M	131.19M	120.03M
Total Debt	11.14M	32.35M	32.25M	37.04M	36.8M	36.56M	36.32M	36.08M	33.57M	33.27M	42.95M	42.67M	79.85M	80.72M	80.19M	107.03M	107.09M	102.03M
Common Stock	7K	6K	6K	5K	5K	3K	3K	3K	3K	2K	2K	1K	73K	73K	66K	65K	65K	64K
Retained Earnings	-688.02M	-676.87M	-667.92M	-659.75M	-650.79M	-641.22M	-629.41M	-620.78M	-612.08M	-601.66M	-587.21M	-574.37M	-603.44M	-575.33M	-542.39M	-494.82M	-466.69M	-430.19M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1K	9K	n/a	n/a	n/a	-1K	-2K	n/a	n/a	n/a	3K
Shareholders Equity	-3.21M	5.71M	12.33M	6.86M	13.72M	6.66M	7.5M	11.22M	17.49M	23.46M	18.97M	-968K	-31.55M	-5.28M	16.8M	61.47M	84.27M	109.79M
Total Investments	226K	239K	246K	260K	273K	287K	301K	314K	9.92M	n/a	462K	n/a	2M	4.99M	1.46M	3.21M	5M	28.02M